AUXILIUM PHARMACEUTICALS INC (AUXL) is a publicly traded company in the Unknown sector. Across all available filings, 41 corporate insiders have executed 601 transactions totaling $141.1M, demonstrating a bearish sentiment with -$65.7M in net insider flow. The most recent transaction on Jan 29, 2015 involved a transaction of 20,000 shares valued at $0.
No significant insider buying has been recorded for AUXL in the recent period.
No significant insider selling has been recorded for AUXL in the recent period.
Based on recent SEC filings, insider sentiment for AUXL is bearish with an Insider Alignment Score of 27/100 and a net flow of -$65.7M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at AUXILIUM PHARMACEUTICALS INC (AUXL) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 41 insiders are actively trading AUXL stock, having executed 601 transactions in the past 90 days. The most active insider is Brothers Life Sciences Capital (gp), Llc Baker (Executive), who has made 14 transactions totaling $34.2M.
Get notified when executives and directors at AUXL file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 29, 2015 | C. Brandt Peter | Executive | Other | 20,000 | $N/A | $0 | |
| Jan 29, 2015 | C. Brandt Peter | Executive | Other | 5,000 | $36.53 | $182.7K | |
| Jan 29, 2015 | A. Classon Rolf | Executive | Other | 260 | $N/A | $0 | |
| Jan 29, 2015 | A. Classon Rolf | Executive | Other | 10,000 | $36.53 | $365.3K | |
| Jan 29, 2015 | Fetzer Oliver | Executive | Other | 10,000 | $36.53 | $365.3K | |
| Jan 29, 2015 | Fetzer Oliver | Executive | Other | 9,197 | $N/A | $0 | |
| Jan 29, 2015 | A. Friedman Paul | Executive | Other | 5,000 | $36.53 | $182.7K | |
| Jan 29, 2015 | A. Friedman Paul | Executive | Other | 5,361 | $N/A | $0 | |
| Jan 29, 2015 | Lurker Nancy | Executive | Other | 10,000 | $36.53 | $365.3K | |
| Jan 29, 2015 | Mckee William | Executive | Other | 10,000 | $36.53 | $365.3K | |
| Jan 29, 2015 | Adams Adrian | Executive | Other | 97,644 | $N/A | $0 | |
| Jan 29, 2015 | Adams Adrian | Executive | Other | 120,134 | $36.53 | $4.4M | Large |
| Jan 29, 2015 | Lou Armstrong Jennifer | Executive | Other | 14,874 | $36.53 | $543.3K | Large |
| Jan 29, 2015 | A. Glickman Mark | Executive | Other | 27,911 | $36.53 | $1.0M | Large |
| Jan 29, 2015 | Varki Jobes Elizabeth | Executive | Other | 13,767 | $36.53 | $502.9K | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 127 | $103.4M | 47.1% |
Other(J) | 31 | $45.6M | 20.8% |
Purchase(P) | 41 | $37.7M | 17.2% |
Exercise(M) | 103 | $23.2M | 10.6% |
Payment(F) | 66 | $5.0M | 2.3% |
Award(A) | 218 | $3.0M | 1.4% |
Exercise (Options)(X) | 2 | $1.5M | 0.7% |
Tender(U) | 2 | $0 | 0.0% |
Gift(G) | 11 | $0 | 0.0% |
Insider selling pressure at AUXILIUM PHARMACEUTICALS INC has increased, with 41 insiders executing 601 transactions across all time. Total sales of $103.4M significantly outpace purchases of $37.7M, resulting in a net outflow of $65.7M. This selling activity appears largely discretionary, which may warrant closer attention from investors.